KLRA · Kailera Therapeutics, Inc. · Documents
Market Cap
$1.98B
Shares
129.64M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-26 | 2026-03-31 | |
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-04-20 | — |
Showing 1–6 of 6 filings
Key facts
CIK
2096997
CUSIP
482931102
13F (30d)
77 filings
77 filers
Visit website
Investor relations